1. Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2
2. Ambler, S. J.; Baker, S. R.; Clark, B. P.; Coleman, D. S.; Foglesong, R. J.; Goldsworthy, J.; Jagdmann, G. E., Jr.; Johnson, K. W.; Kingston, A. E.; Owton, W. M.; Schoepp, D. D.; Hong, J. E.; Schkeryantz, J. M.; Vannieuwenhze, M. S.; Zia-Ebrahimi, M. S. PCT Int. Appl. 2001 WO 2001032632
3. Tyrosine Kinase Inhibitors. 14. Structure−Activity Relationships for Methyl- amino-Substituted Derivatives of 4-[(3-Bromophenyl)amino]-6-(methylamino)- pyrido[3,4-d]pyrimidine (PD 158780), a Potent and Specific Inhibitor of the Tyrosine Kinase Activity of Receptors for the EGF Family of Growth Factors
4. Cockerill, G. S.; Carter, M. C.; Guntrip, S. B.; Smith, K. J. PCT Int. Appl. 1998 WO 9802438
5. Bridges, A. J.; Denny, W. A.; Dobrusin, E. M.; Doherty, A. M.; Fry, D. W.; McNamara, D. J.; Showalter, H. D.; Smail, J. B.; Zhou, H. PCT Int. Appl. 1997 WO 9738983